Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Neuroprotection market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 1.7% during the forecast period.
This report presents the market size and development trends by detailing the Neuroprotection market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Neuroprotection market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Neuroprotection industry and will help you to build a panoramic view of the industrial development.
Neuroprotection Market, By Type:
Free Radical Trapping Agents (Antioxidants)
Glutamate Antagonists (Anti-Excitotoxic Agents)
Apoptosis Inhibitors
Anti-inflammatory Agents
Neurotrophic Factors (NTFs)
Metal Ion Chelators
Stimulants
Others
Neuroprotection Market, By Application:
Prevention
Treatment
Some of the leading players are as follows:
Novartis
Eli Lilly and Company
Biogen
AstraZeneca
Daiichi Sankyo Company
Astrocyte Pharmaceuticals
Teva Pharmaceutical
Allergan
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Neuroprotection Market: Technology Type Analysis
-
4.1 Neuroprotection Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Neuroprotection Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Free Radical Trapping Agents (Antioxidants)
4.3.2 Glutamate Antagonists (Anti-Excitotoxic Agents)
4.3.3 Apoptosis Inhibitors
4.3.4 Anti-inflammatory Agents
4.3.5 Neurotrophic Factors (NTFs)
4.3.6 Metal Ion Chelators
4.3.7 Stimulants
4.3.8 Others
5 Neuroprotection Market: Product Analysis
-
5.1 Neuroprotection Product Market Share Analysis, 2018 & 2026
-
5.2 Neuroprotection Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Neuroprotection Market: Application Analysis
-
6.1 Neuroprotection Application Market Share Analysis, 2018 & 2026
-
6.2 Neuroprotection Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Prevention
6.3.2 Treatment
7 Neuroprotection Market: Regional Analysis
-
7.1 Neuroprotection Regional Market Share Analysis, 2018 & 2026
-
7.2 Neuroprotection Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Novartis
9.1.1 Novartis Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Eli Lilly and Company
9.2.1 Eli Lilly and Company Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Biogen
9.3.1 Biogen Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 AstraZeneca
9.4.1 AstraZeneca Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Daiichi Sankyo Company
9.5.1 Daiichi Sankyo Company Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Astrocyte Pharmaceuticals
9.6.1 Astrocyte Pharmaceuticals Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Teva Pharmaceutical
9.7.1 Teva Pharmaceutical Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Allergan
9.8.1 Allergan Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
The List of Tables and Figures (Totals 78 Figures and 121 Tables)
Figure Free Radical Trapping Agents (Antioxidants) Neuroprotection market, 2015 - 2026 (USD Million)
Figure Glutamate Antagonists (Anti-Excitotoxic Agents) Neuroprotection market, 2015 - 2026 (USD Million)
Figure Apoptosis Inhibitors Neuroprotection market, 2015 - 2026 (USD Million)
Figure Anti-inflammatory Agents Neuroprotection market, 2015 - 2026 (USD Million)
Figure Neurotrophic Factors (NTFs) Neuroprotection market, 2015 - 2026 (USD Million)
Figure Metal Ion Chelators Neuroprotection market, 2015 - 2026 (USD Million)
Figure Stimulants Neuroprotection market, 2015 - 2026 (USD Million)
Figure Others Neuroprotection market, 2015 - 2026 (USD Million)
Figure Prevention market, 2015 - 2026 (USD Million)
Figure Treatment market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Neuroprotection market, by country, 2015 - 2026 (USD Million)
-
Table North America Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table North America Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table North America Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table Canada Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table Canada Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Europe Neuroprotection market, by country, 2015 - 2026 (USD Million)
-
Table Europe Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table Europe Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table Europe Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table Germany Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table Germany Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table France Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table France Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table Italy Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table Italy Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table Spain Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table Spain Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Neuroprotection market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table China Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table China Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table Japan Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table Japan Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table India Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table India Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Neuroprotection market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table MEA Neuroprotection market, by country, 2015 - 2026 (USD Million)
-
Table MEA Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table MEA Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table MEA Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Neuroprotection market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Neuroprotection market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Neuroprotection market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biogen Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Daiichi Sankyo Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Astrocyte Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teva Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Allergan Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
